Vitale, C.; Maglio, A.; Pelaia, C.; D’Amato, M.; Ciampo, L.; Pelaia, G.; Molino, A.; Vatrella, A.
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. J. Clin. Med. 2023, 12, 985.
https://doi.org/10.3390/jcm12030985
AMA Style
Vitale C, Maglio A, Pelaia C, D’Amato M, Ciampo L, Pelaia G, Molino A, Vatrella A.
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of Clinical Medicine. 2023; 12(3):985.
https://doi.org/10.3390/jcm12030985
Chicago/Turabian Style
Vitale, Carolina, Angelantonio Maglio, Corrado Pelaia, Maria D’Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, and Alessandro Vatrella.
2023. "Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting" Journal of Clinical Medicine 12, no. 3: 985.
https://doi.org/10.3390/jcm12030985
APA Style
Vitale, C., Maglio, A., Pelaia, C., D’Amato, M., Ciampo, L., Pelaia, G., Molino, A., & Vatrella, A.
(2023). Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of Clinical Medicine, 12(3), 985.
https://doi.org/10.3390/jcm12030985